West Pharmaceutical Services, Inc.
US ˙ NYSE ˙ US9553061055

SecurityWST / West Pharmaceutical Services, Inc.
InstitutionTrexquant Investment LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Trexquant Investment LP closes position in WST / West Pharmaceutical Services, Inc.

On May 15, 2026 - Trexquant Investment LP filed a 13F-HR form disclosing ownership of 0 shares of West Pharmaceutical Services, Inc. (US:WST) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 43,355 shares of West Pharmaceutical Services, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -100.00 0
2026-02-17 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 43,355 35,184 430.60 11,929 456.60 0.1063
2025-11-14 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 8,171 -30,622 -78.94 2,143 -74.75 0.0221
2025-08-12 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 38,793 -7,393 -16.01 8,488 -17.92 0.0957
2025-05-14 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 46,186 46,186 10,340 0.1203
2025-02-12 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -2,172 -100.00 0 -100.00
2024-11-12 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,172 2,172 652 0.0083
2024-05-14 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -17,005 -100.00 0 -100.00
2024-02-09 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 17,005 17,005 5,988 0.1347
2023-05-15 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -5,935 -100.00 0 -100.00
2023-02-13 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,935 -11,487 -65.93 1,397 -67.44 0.0396
2022-11-14 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 17,422 17,422 4,287 0.1507
2022-02-11 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -613 -100.00 0 -100.00
2021-11-12 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 613 613 260 0.0207
2021-05-13 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -1,714 -100.00 0 -100.00
2021-02-11 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,714 -13,764 -88.93 486 -88.58 0.0515
2020-11-06 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 15,478 15,478 4,255 0.2738
2020-08-07 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -7,451 -100.00 0 -100.00
2020-05-08 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 7,451 1,633 28.07 1,134 29.60 0.0823
2020-02-12 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,818 528 9.98 875 16.67 0.0518
2020-02-18 2019-09-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 5,290 1,966 59.15 750 80.29 0.0648
2019-11-08 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,290 1,966 750 64,775.5656
2019-08-09 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,324 -10,951 -76.71 416 -73.55 0.0374
2019-05-13 2019-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 14,275 2,849 24.93 1,573 40.45 0.1117
2019-02-13 2018-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 11,426 11,426 1,120 0.0700
2018-11-09 2018-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -6,441 -100.00 0 -100.00
2018-08-07 2018-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,441 -4,625 -41.79 640 -34.49 0.0443
2018-05-03 2018-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 11,066 7,601 219.37 977 185.67 0.0681
2018-02-08 2017-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,465 3,465 342 0.0375
2017-11-09 2017-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -4,500 -100.00 0 -100.00
2017-08-01 2017-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,500 -8,447 -65.24 425 -59.79 0.1163
2017-05-08 2017-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 12,947 10,040 345.37 1,057 327.94 0.1356
2017-02-10 2016-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,907 -1,614 -35.70 247 -26.71 0.0391
2016-11-10 2016-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,521 436 10.67 337 8.71 0.0752
2016-08-10 2016-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,085 4,085 0.00 310 0.0407
2015-05-13 2015-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -4,027 -100.00 0 -100.00
2015-02-13 2014-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,027 4,027 214 0.0378
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.